|Human Tissues Contain CD141hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103+ Nonlymphoid Dendritic Cells|
M Haniffa, A Shin, V Bigley, N McGovern, P Teo, P See, PS Wasan, ...
Immunity 37 (1), 60, 2012
|The immune response during hepatitis B virus infection|
A Bertoletti, AJ Gehring
Journal of General Virology 87 (6), 1439-1449, 2006
|Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection|
O Franzese, PTF Kennedy, AJ Gehring, J Gotto, R Williams, MK Maini, ...
Journal of virology 79 (6), 3322-3328, 2005
|Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing|
AJ Gehring, KM Dobos, JT Belisle, CV Harding, WH Boom
The Journal of Immunology 173 (4), 2660-2668, 2004
|Human immunity to M. tuberculosis: T cell subsets and antigen processing|
WH Boom, DH Canaday, SA Fulton, AJ Gehring, RE Rojas, M Torres
Tuberculosis 83 (1-3), 98-106, 2003
|IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells|
XZ Tang, J Jo, AT Tan, E Sandalova, A Chia, KC Tan, KH Lee, AJ Gehring, ...
The Journal of Immunology 190 (7), 3142-3152, 2013
|Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function|
ND Pecora, AJ Gehring, DH Canaday, WH Boom, CV Harding
The Journal of immunology 177 (1), 422-429, 2006
|Bim-mediated deletion of antigen-specific CD8+ T cells in patients unable to control HBV infection|
AR Lopes, P Kellam, A Das, C Dunn, A Kwan, J Turner, D Peppa, ...
The Journal of clinical investigation 118 (5), 1835-1845, 2008
|Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients|
V Chew, C Tow, M Teo, HL Wong, J Chan, A Gehring, M Loh, A Bolze, ...
Journal of hepatology 52 (3), 370-379, 2010
|The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and FcγR1 on human macrophages through Toll-like receptor 2|
AJ Gehring, RE Rojas, DH Canaday, DL Lakey, CV Harding, WH Boom
Infection and immunity 71 (8), 4487-4497, 2003
|Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines|
AJ Gehring, SA Xue, ZZ Ho, D Teoh, C Ruedl, A Chia, S Koh, SG Lim, ...
Journal of hepatology 55 (1), 103-110, 2011
|Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma|
AJ Gehring, ZZ Ho, AT Tan, MO Aung, KH Lee, KC Tan, SG Lim, ...
Gastroenterology 137 (2), 682-690, 2009
|Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver|
J Jo, AT Tan, JE Ussher, E Sandalova, XZ Tang, A Tan-Garcia, N To, ...
PLoS pathogens 10 (6), 2014
|A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B|
AT Tan, S Koh, W Goh, HY Zhe, AJ Gehring, SG Lim, A Bertoletti
Journal of hepatology 52 (3), 330-339, 2010
|Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient|
W Qasim, M Brunetto, AJ Gehring, SA Xue, A Schurich, A Khakpoor, ...
Journal of hepatology 62 (2), 486-491, 2015
|Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire|
AT Tan, E Loggi, C Boni, A Chia, AJ Gehring, KSR Sastry, V Goh, ...
Journal of virology 82 (22), 10986-10997, 2008
|Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection|
S Tavakoli, I Mederacke, S Herzog‐Hauff, D Glebe, S Grün, D Strand, ...
Clinical & Experimental Immunology 151 (1), 61-70, 2008
|The role of innate immunity in the immunopathology and treatment of HBV infection|
MK Maini, AJ Gehring
Journal of hepatology 64 (1), S60-S70, 2016
|Trained immunity in newborn infants of HBV-infected mothers|
M Hong, E Sandalova, D Low, AJ Gehring, S Fieni, B Amadei, S Urbani, ...
Nature communications 6 (1), 1-12, 2015
|A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus|
S Koh, N Shimasaki, R Suwanarusk, ZZ Ho, A Chia, N Banu, SW Howland, ...
Molecular Therapy-Nucleic Acids 2, e114, 2013